Propofol Injection, Emulsion
Product Images NDC 72572-601

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Propofol (NDC 72572-601). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civica, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Propofol 01)

Chemical structure of propofol, showing the molecular arrangement with hydroxyl group and isopropyl groups attached to a benzene ring.*

FDA Label Image

Figure (Propofol 02)

A line graph showing plasma propofol concentration (mg/mL) over time in minutes after the end of infusion. The graph includes three curves representing recovery after 1-hour, 10-hour, and 10-day infusions, with plasma concentration decreasing over time and approaching the awakening threshold.*

FDA Label Image

Principal Display Panel (20 mL Vial Label)

Label for Propofol Injectable Emulsion, USP, 200 mg/20 mL (10 mg/mL) intravenous injection emulsion. The single patient use vial is labeled by Civica, Inc. and includes storage instructions, usage warnings such as 'Shake well before using,' and a note to use aseptic technique. It lists ingredients and distributor information, with space for lot number, expiry date, discard date, and time.*

FDA Label Image

Principal Display Panel (20 mL Vial Carton)

Propofol Injectable Emulsion, USP 200 mg/20 mL (10 mg/mL) carton label from Civica, Inc. The label specifies intravenous administration, ten 20 mL vials for single patient use, and includes storage and handling instructions such as to store between 4 to 25°C and to shake well before using. It highlights the need for aseptic technique and warns that the product contains EDTA, inhibiting microbial growth up to 12 hours after opening, and must be discarded within 12 hours. The label features barcodes, lot and expiration placeholders, and manufacturer details.*

FDA Label Image

Principal Display Panel (50 mL Vial Label)

Propofol Injectable Emulsion USP 500 mg/50 mL (10 mg/mL) single patient use vial label. The label includes usage instructions to shake well before use, strict aseptic technique warnings, and storage conditions between 40 to 77°F (4 to 25°C). Manufactured by Civica, Inc, the label also includes lot number, expiration date sections, and drug composition details.*

FDA Label Image

Principal Display Panel (50 mL Vial Carton)

Label for Propofol Injectable Emulsion, USP, 500 mg/50 mL (10 mg/mL) injection, emulsion for intravenous use. The label states it contains twenty 50 mL vials for single patient use and includes instructions to shake well before using. The product is labeled as Rx Only and distributed by Civica, Inc.*

FDA Label Image

Principal Display Panel (100 mL Vial Label)

Label for Propofol Injectable Emulsion, USP 10 mg/mL (1000 mg/100 mL) intravenous injection by Civica, Inc. The single-patient-use vial label includes storage instructions, aseptic technique warnings, ingredient details, and directions to shake well before use. Barcode and lot/expiry date fields are also visible.*

FDA Label Image

Principal Display Panel (100 mL Vial Carton)

Packaging label for Propofol Injectable Emulsion, USP 1000 mg/100 mL (10 mg/mL) intravenous injection by Civica, Inc. The label states ten 100 mL vials for single patient use with instructions to shake well before using. It includes sterile, nonpyrogenic information and cautions about using aseptic technique and EDTA presence. The label features dosing and storage warnings, barcodes, and distributor details on a white background with blue and red text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.